GELESIS HOLDINGS, INC. — Form D

GELESIS HOLDINGS, INC. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-24. The offering totals $50.6M, of which $576K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2022-08-24
Form: D
Accession: 0001802806-22-000008
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $50.6M
Amount sold: $576K
Remaining: $50.0M
Investors: 1
Date of first sale: 2022-08-11
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-456915

Issuer

Name: GELESIS HOLDINGS, INC.
CIK: 0001805087
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 501 BOYLSTON STREET, SUITE 6102, BOSTON, MA, 02116
Phone: 617-456-4718

Officers, directors & promoters (15)

Name	Role	Location
Alison L Bauerlein	Director	BOSTON, MA
Kathryn L Cavanaugh	Director	BOSTON, MA
Clayton L Christopher	Director	BOSTON, MA
Paul L Fonteyne	Director	BOSTON, MA
Raju L Kucherlapati	Director	BOSTON, MA
Dominic L Perks	Director	BOSTON, MA
Jane L Wildman	Director	BOSTON, MA
Yishai Zohar	Director	BOSTON, MA
David L Abraham	Executive Officer	BOSTON, MA
Elaine L Chiquette	Executive Officer	BOSTON, MA
Harry L Leider	Executive Officer	BOSTON, MA
Elliot L Maltz	Executive Officer	BOSTON, MA
David Pass	Executive Officer	Palo Alto, CA
Alessandro L Sannino	Executive Officer	BOSTON, MA
Yishai Zohar	Executive Officer	BOSTON, MA

More